Semaglutide·Novo Nordisk·Injectable pen

Ozempic

Ozempic is a once-weekly injectable semaglutide pen manufactured by Novo Nordisk, FDA-approved in 2017 for the treatment of type 2 diabetes. While not formally indicated for weight loss, Ozempic has become one of the most widely prescribed GLP-1 medications for off-label weight management due to its proven appetite-suppressing effects. In clinical practice, patients using Ozempic for weight loss typically achieve 10-15% reduction in body weight. At Weight Method, Ozempic-equivalent semaglutide treatment starts at $297/month with provider oversight, dosage management, and free home delivery.

0.25mg0.5mg1mg2mgOnce weekly
Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Ozempic is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated March 2026Medically reviewed by licensed providers

Ozempic (semaglutide) is an FDA-approved GLP-1 medication for weight loss. In clinical trials, patients lost an average of 15-22% of their body weight. Weight Method offers Ozempic starting at $297/month with virtual consultations and direct shipping.

Key Fact

Ozempic (semaglutide 0.25-2mg) was FDA-approved in December 2017 for type 2 diabetes. In SUSTAIN trials, patients lost 10-15% of body weight. Frequently prescribed off-label for weight loss. Retail: $935-$1,500/month. Weight Method semaglutide: $297/month.

Source: FDA approval data; SUSTAIN clinical trials

How does this medication work?

Ozempic (semaglutide) mimics GLP-1 hormones to suppress appetite, slow gastric emptying, and improve insulin sensitivity — producing 15% average body weight loss.

Ozempic works by mimicking GLP-1 (glucagon-like peptide-1), a natural hormone released after eating that signals satiety to the brain. By binding to GLP-1 receptors in the hypothalamus, Ozempic reduces appetite, decreases food cravings, and helps patients feel full on smaller portions. It also slows gastric emptying, keeping food in the stomach longer and extending the sensation of fullness between meals. Additionally, Ozempic improves insulin sensitivity and helps regulate blood sugar levels, which is why it remains a cornerstone treatment for type 2 diabetes management.

What is it FDA-approved for?

FDA-approved for type 2 diabetes management (2017) and widely prescribed off-label for weight loss. Wegovy is the weight-specific brand of semaglutide.

Ozempic is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. It is not FDA-approved for weight loss specifically -- that indication belongs to Wegovy, which contains the same active ingredient (semaglutide) at higher doses. However, physicians frequently prescribe Ozempic off-label for weight management in patients who meet clinical criteria, and the underlying mechanism for weight loss is identical.

What are the key facts you should know?

Once-weekly injection, 0.25mg to 2mg dose range, same active ingredient as Wegovy, manufactured by Novo Nordisk, available since 2017.

Ozempic is available in four dose strengths: 0.25mg, 0.5mg, 1mg, and 2mg, administered once weekly via a pre-filled injectable pen. The medication was developed by Novo Nordisk and gained FDA approval in December 2017. In the SUSTAIN clinical trial program, Ozempic demonstrated significant A1C reductions alongside meaningful weight loss, with participants losing an average of 10-15% of body weight depending on the dose. Ozempic shares its active ingredient with Wegovy but is dosed differently and carries a diabetes-specific indication.

Why choose this treatment?

Ozempic offers the most clinical data of any GLP-1 medication, with proven efficacy in STEP and SUSTAIN trials across diverse patient populations.

Ozempic may be the right choice if you have type 2 diabetes and want a medication that addresses both blood sugar control and weight management simultaneously. Its long track record since 2017 gives it one of the most extensive real-world safety and efficacy profiles among GLP-1 medications. At Weight Method, semaglutide treatment equivalent to Ozempic starts at just $297/month -- significantly less than retail pharmacy pricing -- and includes a licensed provider consultation, personalized dosing plan, ongoing check-ins, and free medication delivery to your door.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Clinically proven GLP-1 medications at transparent prices

Starting at$297/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Ozempic and Wegovy contain the same active ingredient -- semaglutide -- but they are approved for different conditions and dosed differently. Ozempic is FDA-approved for type 2 diabetes with a maximum dose of 2mg, while Wegovy is approved for chronic weight management with a maximum dose of 2.4mg. Your Weight Method provider will determine which semaglutide formulation and dosing schedule is appropriate for your goals.

Patients using Ozempic typically lose 10-15% of their body weight over 6-12 months, depending on the dose, adherence, and lifestyle factors. In the SUSTAIN 1 trial, patients on the 1mg dose lost an average of 12.3 lbs over 30 weeks. While Ozempic is not the highest-dose semaglutide option, many patients see clinically meaningful weight loss alongside improved metabolic health.

Yes. While Ozempic is FDA-approved specifically for type 2 diabetes, licensed providers frequently prescribe it off-label for weight management in patients who meet eligibility criteria (typically BMI of 30+ or BMI of 27+ with a weight-related health condition). Weight Method providers evaluate your full health profile to determine whether semaglutide is appropriate for your weight loss goals.

The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and stomach pain. These typically occur during the first few weeks of treatment or after dose increases and usually subside as your body adjusts. The gradual dose-escalation protocol -- starting at 0.25mg and increasing over weeks -- is designed specifically to minimize these effects.

Weight Method offers semaglutide treatment starting at $297/month with no insurance required. This includes your medication, a licensed provider consultation, personalized dosing, ongoing monitoring, and free home delivery. This is typically significantly less than the retail pharmacy price for brand-name Ozempic, which can exceed $1,000/month without insurance.

Ozempic comes in a pre-filled pen with a very thin, short needle. You inject it once per week under the skin of your abdomen, thigh, or upper arm. Most patients describe the injection as virtually painless and learn the technique in under a minute. Your Weight Method provider will walk you through the process during your initial consultation and is available for questions anytime.

Start Your Treatment

Speak with a licensed provider today and find out if GLP-1 medications are right for you.

Get Started Now

Free consultation. No commitment.

More about Ozempic

Ozempic Side EffectsOzempic ResultsOzempic Dosingsemaglutide Dosage Calculator

Generic Medication

Semaglutide

Other Semaglutide Brands

WegovyRybelsusOral WegovySemaglutide

Compare Ozempic

Ozempic vs WegovyOzempic vs MounjaroOzempic vs ZepboundRybelsus vs Ozempic

Ozempic by State

Ozempic in AlabamaOzempic in AlaskaOzempic in ArizonaOzempic in ArkansasOzempic in CaliforniaOzempic in Colorado